It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Fluvoxamine is traditionally used to treat mental health conditions such as depression and obsessive-compulsive disorders and was selected for trial due to its anti-inflammatory properties.
Many problems stemming from Covid are caused by swelling as the immune system over-reacts to the infection.
Side effects There are the following side effects of fluvoxamine ● Headache ● Weakness ● Nausea ● Somnolence ● Dizziness ● Insomnia ● Diarrhea ● Anorexia ● Abnormal ejaculation ● Xerostomia ● Pain ● Constipation ● Upper respiratory infections ● Anxiety ● Sweating ● Dyspepsia ● Decreased libido ● Tremor ● Vomiting ● Abnormal taste ● Abnormal dreams ● Myalgia ● Chest pain ● Abnormal thinking ● Abdominal pain ● Palpitation ● Vasodilation ● Agitation ● Hypertension ● Weight change ● Increased LFTs ● Edema ● Manic reaction ● Malaise ● Amnesia ● Sinusitis ● Activation of mania/hypomania, seizures ● Apathy ● Myoclonus ● Asthenia ● Nervousness ● Dry mouth ● Cough
Fluvoxamine is traditionally used to treat mental health conditions such as depression and obsessive-compulsive disorders and was selected for trial due to its anti-inflammatory properties.
originally posted by: incoserv
originally posted by: MDDoxs
a reply to: Nyiah
...
Ivermectin and the product from Merck is more appealing to me.
Isn't that kind of like saying, "Fresh squeezed orange juice and hydrochloric acid are more appealing to me?"
What a pile of horse💩.
The CDC now says mood disorders put people at a higher risk of severe COVID-19 infection.
The determination allows people with the diagnoses to be eligible for COVID-19 booster shots.
A recent analysis found a link between mood disorders and risk of severe and fatal COVID-19.
The addition of "mood disorders, including depression, and schizophrenia spectrum disorders," which was made earlier this month, allows those with mental illness to be eligible for COVID-19 vaccine booster shots.
originally posted by: Nyiah
A specific one, rather:
Fluvoxamine is traditionally used to treat mental health conditions such as depression and obsessive-compulsive disorders and was selected for trial due to its anti-inflammatory properties.
Many problems stemming from Covid are caused by swelling as the immune system over-reacts to the infection.
www.msn.com...
As my husband pointed out, "Wonder who paid for the "study". And how long they think they can milk doping the country up before people catch on head meds for a cold is seriously #ed up." There's no way I can say it better myself, he's not wrong at all! Why settle for this, when there's already anti-inflammation meds out there to prescribe? It seriously smells like a blatant "heath racketeering" controversy here.
Yes, I know, OL use is nothing new, I've had an OL prescription myself. Didn't do me a damn lick of good for what it was prescribed for, & screwed the hell out of my body's ability to retain a sleep schedule (FYI, amitriptyline for migraines didn't do much for the migraines, but did a lot for ruining my Sleep Mode start ability here)
Either that, or we can infer that Covid reactions are placebo reactions all in your head and that was a subtle nod to it. This is about where I say, "It's all bull#, folks. Now they're going for the OL-use brain drug pitches."